Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6602423.pdf
Reference27 articles.
1. Albrecht TL, Blanchard C, Ruckdeschel JC, Coovert M, Strongbow R (1999) Strategic Physician Communication and Oncology Clinical Trials. J Clin Oncol 17: 3324–3332
2. Appelbaum PS, Roth LH, Lidz CW, Benson P, Winslade W (1987) False hopes and best data: consent to research and the therapeutic misconception. Hastings Cent Rep 17: 20–24
3. Bain NSC, Campbell NC, Ritchie LD, Cassidy J (2002) Striking the right balance in colorectal cancer care – a qualitative study of rural and urban patients. Fam Pract 19: 369–374
4. Cheng JD, Hitt J, Koczwara B, Shulman KA, Burnett CB, Gaskin DJ, Rowland JH, Meropol NJ (2000) Impact of quality of life on patient expectations regarding phase I clinical trials. J Clin Oncol 18: 421–428
5. Cox K (2002) Informed consent and decision making: patients' experiences of the process of recruitment to phase I and phase II anti-cancer trials. Patient Educ Couns 46: 31–38
Cited by 118 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluation of drug litigation against the Campinas municipal health system from 2017 to 2021;Scientific Reports;2024-08-13
2. Patient Experience of Complex Genomic Sequencing Exploring Patient Preference, Barriers, and Enablers for Delivery;JCO Precision Oncology;2024-08
3. Risk preferences over health: Empirical estimates and implications for medical decision-making;Journal of Health Economics;2024-03
4. Participants’ understanding of informed consent in clinical trials: A systematic review and updated meta-analysis;PLOS ONE;2024-01-02
5. The compassionate use of drugs in palliative care for symptom control and ethical justifications for its use: A scoping review;Ethics, Medicine and Public Health;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3